Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Obesity × Pregabalin × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Breast Neoplasms 5 Pain 2 Obesity 1 Myotoxicity 1 Lymphoma 1 Inflammation 1 Hot Flashes 1 Drug-Related Side Effects and Adverse Reactions 1 Chronic Pain 1 Breast Cancer Patient 1 Agnosia 1

Interventions

Exercise 8 exemestane 3 Tamoxifen 3 Metformin 3 Early Intervention, Educational 3 Diet Therapy 3 Vitamin D 2 Sugars 2 Specimen Handling 2 Naltrexone 2 Methods 2 Mammography 2 Letrozole 2 Diet, Mediterranean 2 Counseling 2 Cognitive Behavioral Therapy 2 Cholecalciferol 2 Bupropion 2 Blood Specimen Collection 2 Bariatric Surgery 2 Anastrozole 2 rosiglitazone-metformin combination 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Yoga 1 Walking 1 Tirzepatide 1 Tablets 1 Soybean Proteins 1 Rosiglitazone 1 Psychology, Positive 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡